APL-2 Prevents Both C3 And C5 Convertase Formation And Activity: A Potential Therapeutic For Renal Diseases - Apellis Medical Hub

APL-2 Prevents Both C3 And C5 Convertase Formation And Activity: A Potential Therapeutic For Renal Diseases

Share Via Email

Back to Conference Resources

Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) and C3 Glomerulopathy (C3G) American Society of Nephrology (ASN) 2019

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.